Post-stroke emotionalism: Diagnosis, pathophysiology, and treatment

Broomfield, Niall M. ORCID: https://orcid.org/0000-0003-2599-3435, Blake, Joshua ORCID: https://orcid.org/0000-0002-4105-3825, Gracey, Fergus ORCID: https://orcid.org/0000-0002-1416-7894 and Steverson, Tom ORCID: https://orcid.org/0009-0003-1814-1610 (2024) Post-stroke emotionalism: Diagnosis, pathophysiology, and treatment. International Journal of Stroke, 19 (8). pp. 857-866. ISSN 1747-4930

[thumbnail of broomfield-et-al-2024-post-stroke-emotionalism-diagnosis-pathophysiology-and-treatment]
Preview
PDF (broomfield-et-al-2024-post-stroke-emotionalism-diagnosis-pathophysiology-and-treatment) - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (303kB) | Preview

Abstract

Background: Post-stroke emotionalism affects one in five stroke sufferers 6 months after their stroke, but despite its frequency remains a poorly understood stroke symptom. The literature is limited, especially compared to other frequently observed neurological conditions such as aphasia and visual neglect. Aim and Methods: This narrative review presents a summary of the post-stroke emotionalism literature, to inform clinical practice and future research. We cover discussion of definitions, prevalence, neurobiology, predisposing and precipitating factors, and treatment. Results: Increasing evidence suggests that damage to specific areas functionally linked to emotion expression or regulation processes, disruption to structural pathways and those related to serotonin production and modulation individually or in concert give rise to emotionalism-type presentations. A range of emotionalism measurement tools have been used in research contexts making between study comparisons difficult. Testing for Emotionalism after Recent Stroke–Questionnaire (TEARS-Q) has recently been developed to allow standardized assessment. Treatment options are limited, and there have been few adequately powered treatment trials. Antidepressants may reduce severity, but more trial data are required. There have been no randomized-controlled trials of non-pharmacological interventions. Conclusions: More research is needed to improve recognition and treatment of this common and disabling symptom. We conclude with research priorities and recommendations for the field.

Item Type: Article
Additional Information: Funding information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Professor N.M.B. is Chief Investigator of EASE, NIHR HTA funded clinical trial of sertraline for post-stroke emotionalism (NIHR152423).
Uncontrolled Keywords: stroke,clinical psychology,emotionalism,neuropsychiatry,neuropsychology,rehabilitation,neurology,clinical neurology ,/dk/atira/pure/subjectarea/asjc/2800/2808
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 12 Apr 2024 08:30
Last Modified: 18 Dec 2024 01:37
URI: https://ueaeprints.uea.ac.uk/id/eprint/94898
DOI: 10.1177/17474930241242952

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item